HLA Alloimmunization Following Ventricular Assist Device Support Across the Age Spectrum

Volume: 103, Issue: 12, Pages: 2715 - 2724
Published: Dec 1, 2019
Abstract
Ventricular assist device (VAD) therapy has become an important tool for end-stage heart failure. VAD therapy has increased survival but is associated with complications including the development of human leukocyte antigen (HLA) antibodies. We sought to determine the incidence of HLA antibody development post-VAD insertion, across the age spectrum, in patients receiving leukocyte-reduced blood products, with standardized HLA antibody detection...
Paper Details
Title
HLA Alloimmunization Following Ventricular Assist Device Support Across the Age Spectrum
Published Date
Dec 1, 2019
Volume
103
Issue
12
Pages
2715 - 2724
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.